Charles Elliott Sigal - Jul 3, 2023 Form 4 Insider Report for Adaptimmune Therapeutics PLC (ADAP)

Role
Director
Signature
/s/ Charles Elliott Sigal
Stock symbol
ADAP
Transactions as of
Jul 3, 2023
Transactions value $
$0
Form type
4
Date filed
7/3/2023, 05:02 PM
Previous filing
May 24, 2023
Next filing
Sep 8, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price was converted from GBP0.12 based on an exchange rate of $U.S. 1.270841 to GBP1.00. The actual exercise price will be the pounds sterling amount.